Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Prevention of Preeclampsia in High-Risk Pregnant Women
NCT07373756Phase 4Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised, open-label trial of aspirin in preeclampsia (2 arms). Primary endpoint: Incidence of Preeclampsia. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT07373756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07373756.